Newsroom | 42328 results

WENDELSHEIM, Germany--(BUSINESS WIRE)--MODAG GmbH announced it has received a $1 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is part of MJFF’s strategic research agenda focused on supporting objective tools to biologically measure and track the progression of Parkinson’s disease (PD) to improve clinical trial design. The Foundation will support continued advancement of MODAG's innovative PET tracer programs, which enable earlier and mo...

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional (HCP) experiences, enabling teams to focus on strategic and meaningful customer interactions. Building upon its existing investments with Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft f...

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, “Strengthening Belonging for Underserved Boys.” The report explores how loneliness has become a pressing public health issue among boys, particularly those from racially and ethnically diverse backgrounds, rural communities, LGBTQ+ identities, and boys with differing physical and mental abilities. According to a Gallup poll, 25%...

GALWAY, Ireland--(BUSINESS WIRE)--AVeta Medical, developer of the VITA AV™ platform, today announced the appointment of Karen Noblett, M.D. as CEO. Eileen Duffy, who served as interim CEO, has been appointed Chair of the Board of Directors. “Karen’s deep experience leading clinical programs, guiding regulatory strategy, and scaling med-tech innovation aligns directly with AVeta’s next phase of growth,” said Eileen Duffy, incoming Chair of AVeta’s Board of Directors. A nationally recognized lead...

SAN FRANCISCO--(BUSINESS WIRE)--SleepRes, Inc. has received U.S. FDA 510(k) clearance for the Kricket PAP device, powered by KPAP™....

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming J.P. Morgan 44th Annual Healthcare Conference. AtriCure’s management is scheduled to present on Wednesday, January 14, 2026, at 10:30 a.m. Pacific Standard Time. Interested parties may access a live aud...

チューリッヒ--(BUSINESS WIRE)--（ビジネスワイヤ） -- ABBは、電気診断分野で30年以上の専門知識を有する英国拠点のテクノロジー企業であるIPECを買収する契約を締結したことを発表しました。IPECの高度な監視システムは、AIと高度な分析を活用し、データセンター、医療、ユーティリティ、製造業などの業界において数百万ドル規模の損失や安全上のリスク、長時間の停電につながる可能性のある故障を予測するため、重要な電気インフラを24時間体制で監視しています。本取引は2026年第1四半期に完了する見込みです。取引金額は公表されていません。 この買収は、世界で最も重要な産業分野におけるオペレーショナル・レジリエンスの確保に取り組むABBの姿勢をさらに強化するものです。部分放電現象は、機器の絶縁劣化の初期段階を示す微小な電気スパークであり、予期せぬ停止が発生する前の設備故障の80%以上の原因となる、主要な故障要因です。IPECは部分放電の検知を専門としており、これにより、企業は高額なダウンタイムへと発展する前に問題を特定できます。その結果、今日のエネルギーおよび運用上の負荷に耐...

ZURICH--(BUSINESS WIRE)--ABB a annoncé aujourd’hui avoir conclu un accord en vue d’acquérir IPEC, une entreprise technologique britannique forte de plus de 30 ans d’expertise dans le domaine du diagnostic électrique. Les systèmes de surveillance avancés d’IPEC surveillent 24 heures sur 24 les infrastructures électriques critiques, en utilisant l’IA et des analyses avancées pour prédire les pannes qui pourraient entraîner des pertes de plusieurs millions de dollars, des risques pour la sécurité...

WENDELSHEIM, Deutschland--(BUSINESS WIRE)--Die MODAG GmbH gab heute bekannt, dass sie Fördermittel in Höhe von 1 Million US-Dollar von der Michael J. Fox Foundation for Parkinson’s Research (MJFF) erhalten hat. Diese Mittel sind Teil der strategischen Forschungsförderung der MJFF, die darauf abzielt, die Entwicklung objektiver Methoden zu unterstützen, die es ermöglichen bei Patienten mit Parkinson das Fortschreiten der Krankheit auf molekularer Ebene zu verfolgen. Dies soll auch das Design kli...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, the AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications validating its POSH (Pooled Optical Screening in Human cells) platform. The study details the development of CellPaint-POSH, a scalable approach that integrates pooled CRISPR screening, high-content imaging, and advanced machine learning to map gene function at scale without relying on predefined biomarkers or human-engi...